Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002898895 | SCV003236203 | likely benign | Kabuki syndrome | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004758891 | SCV005363641 | uncertain significance | KMT2D-related disorder | 2024-03-05 | no assertion criteria provided | clinical testing | The KMT2D c.11754G>T variant is predicted to result in the amino acid substitution p.Gln3918His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0034% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |